Source: The Women's Health Group Blog

The Women's Health Group Blog Urogynecologic Surgical Mesh Implants

Yesterday, April 16, 2019, the FDA announced an order for Boston Scientific and Coloplast to stop selling pelvic mesh. These products were designed to help women with pelvic support disorders such as uterine prolapse or cystocele. They were initially approved for use in 2002 and in 2016 were placed in a special category requiring additional […]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Stephen Volin's photo - Managing Director of The Women's Health Group

Managing Director

Stephen Volin

CEO Approval Rating

90/100

Read more